Form 4: Director Edward Breen Acquires DuPont Shares

DuPont de Nemours, Inc. director Edward Breen acquired 4,030 shares of common stock as part of a compensation-related transaction.

Summary

• Director Edward Breen acquired 4,030 shares of DuPont de Nemours, Inc. (DD) common stock.
• The transaction occurred on May 21, 2026.
• The shares were acquired at a price of $0, indicating a grant or equity-based compensation award.
• Following this transaction, Edward Breen's total beneficial ownership increased to 278,007.876 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.

Positives

• Increased equity stake by a member of the Board of Directors signals alignment with shareholder interests.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices intended to incentivize long-term leadership commitment within the chemical and materials science sector.

Comparison to Industry Standards

• The acquisition of equity by directors is consistent with standard compensation practices for S&P 500 companies like DuPont.
• The transaction size is immaterial relative to the total market capitalization of DuPont.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• None.

Key Dates

Keywords

DuPont, DD, Form 4, Insider Trading, Equity Compensation, Edward Breen